CMTX BIOTECH

cmtx-biotech-logo

CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients. It is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of its drug candidate in hospitalized COVID-19 patients. The company was founded in 2019 and is headquartered in Stony Brook, New York.

#People #Website #More

CMTX BIOTECH

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2019-01-01

Address:
Stony Brook, New York, United States

Country:
United States

Website Url:
http://www.cmtxbiotech.com

Total Employee:
1+

Status:
Active

Contact:
631 258 5680

Email Addresses:
[email protected]


Current Employees Featured

james-keane_image

James Keane
James Keane Co-Founder & COO @ CMTx Biotech
Co-Founder & COO

carlos-n-velez_image

Carlos N. Velez
Carlos N. Velez Vice President Of Business Development @ CMTx Biotech
Vice President Of Business Development
2020-04-01

joseph-scaduto_image

Joseph Scaduto
Joseph Scaduto Co-Founder & CEO @ CMTx Biotech
Co-Founder & CEO

Founder


james-keane_image

James Keane

joseph-scaduto_image

Joseph Scaduto

lorne-golub_image

Lorne Golub

Official Site Inspections

http://www.cmtxbiotech.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "CMTx Biotech"

CMTx Biotech - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 631 258 5680 CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule …See details»

CMTX BIOTECH, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for CMTX BIOTECH, INC. of Kings Park, NY. Get the latest business insights from Dun & Bradstreet.See details»

CMTx Biotech Company Profile 2024: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for CMTx Biotech. Use the PitchBook Platform to explore the full profile.See details»

CMTx Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore CMTx Biotech, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

CMTx Biotech, Inc. | LinkedIn

CMTx Biotech, Inc. Biotechnology Stony Brook, New York 1,394 followers Commercializing proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations.See details»

CMTx Biotech, Inc.: Contact Details and Business Profile

CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of …See details»

CMTx Biotech - Products, Competitors, Financials, Employees ...

Cmtxbiotech.com. Overview & Products; Financials; People; Founded Year 2019. Stage Other Investors | Alive. About CMTx Biotech. CMTx Biotech focuses on developing small molecule …See details»

CMTx Biotech - Overview, News & Similar companies - ZoomInfo

View CMTx Biotech (www.cmtxbiotech.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»

CMTx Biotech - Org Chart, Teams, Culture & Jobs - The Org

CMTx Biotech is a clinical-stage biopharmaceutical company that is developing an orally administered small molecule for the treatment of sepsis patients at risk of Acute Respiratory …See details»

CMTx Biotech, Inc. | VentureRadar

Similar Companies: Can-Fite Israel Privately Held Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a …See details»

CMTx Biotech Executes Exclusive License Agreement with Galderma

Kings Park, NY; March 15, 2021: CMTx Biotech announced today that it has executed an exclusive, worldwide license agreement to develop and commercialize incyclinide, a clinical …See details»

CMTx Biotech

CMTx Biotech is focused on developing innovative therapies for rare and pandemic diseases. Their research centers around the repurposing of chemically-modified tetracycline (CMT) …See details»

CMTx Biotech Inc. - BIO International Convention | BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. CMTx Biotech Inc. - BIO …See details»

CMTx Biotech Submits pre-IND Meeting Request and Briefing

Kings Park, NY; May 18, 2021: CMTx Biotech announced today that it has submitted a pre-IND Meeting Request and Briefing Document to the U.S. Food and Drug Administration (FDA), …See details»

Clarametyx raises $33M to develop non-antibiotic CF treatment

Jan 8, 2024 Phase 1b/2a trial to test CF treatment candidate CMTX-101 in 41 adults. CF is caused by mutations in the CFTR gene, resulting in the abnormal accumulation of thick and …See details»

CMTx Biotech, Inc. Receives $315,000 NCATS Grant

CMTx Biotech announced today that it has received a $315,000 Clinical Trial Planning Grant from the National Center for Advancing Translational Sciences (NCATS), one of the 27 Institutes …See details»

Publications - CMTx Biotech, Inc.

Abstract Excerpt: Kaposi's sarcoma (KS) is an angioproliferative lesion that may regress or progress. Progression is related to spindle cell proliferation and the expression of human …See details»

Newsroom - CMTx Biotech, Inc.

Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic DiseasesSee details»

CMTx Biotech Shifting to Meet Pandemic Needs

CMTx Biotech is in the news today as one of a few Long Island companies refocusing their efforts to help fight the COVID-19 pandemic. CMTx Biotech is repurposing a clinical stage drug …See details»